Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
“With low uptake of PrEP among the communities most impacted by HIV, this insurance coverage requirement with ... healthcare ...
PrEP is a medication that helps prevent HIV infection, and its inclusion would be a significant ... among hijra/transgender people is 18 times and among people who use drugs is 43 times of the overall ...
The new rule was contained within a larger proposal to ensure contraceptive coverage in the face of Republican attacks.
GlobalData on MSN2d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...
Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback